These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 29619895)
1. Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning. Ørvim Sølvik U; Risøy AJ; Kjome RLS; Sandberg S J Diabetes Sci Technol; 2018 Jul; 12(4):753-761. PubMed ID: 29619895 [TBL] [Abstract][Full Text] [Related]
2. Availability and analytical quality of hemoglobin A1c point-of-care testing in general practitioners' offices are associated with better glycemic control in type 2 diabetes. Tollånes MC; Jenum AK; Berg TJ; Løvaas KF; Cooper JG; Sandberg S Clin Chem Lab Med; 2020 Jul; 58(8):1349-1356. PubMed ID: 32229656 [TBL] [Abstract][Full Text] [Related]
3. Diagnosing diabetes mellitus: performance of hemoglobin A1c point-of-care instruments in general practice offices. Sølvik UØ; Røraas T; Christensen NG; Sandberg S Clin Chem; 2013 Dec; 59(12):1790-801. PubMed ID: 23958846 [TBL] [Abstract][Full Text] [Related]
4. Implementation of point-of-care HbA1C instruments into community pharmacies: Initial development of a pathway for robust community testing. Radley A; Beer L; Rushdi D; Close H; McBurney S; Mackenzie A; Gourlay A; Barnett A; Grant A; Greig N; Dow E; Sutherland C Ann Clin Biochem; 2024 Jul; 61(4):273-283. PubMed ID: 37996254 [TBL] [Abstract][Full Text] [Related]
5. Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study. Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ PLoS One; 2018; 13(2):e0191316. PubMed ID: 29474501 [TBL] [Abstract][Full Text] [Related]
6. Commutability of a Whole-Blood External Quality Assessment Material for Point-of-Care C-Reactive Protein, Glucose, and Hemoglobin Testing. Bukve T; Sandberg S; Vie WS; Sølvik U; Christensen NG; Stavelin A Clin Chem; 2019 Jun; 65(6):791-797. PubMed ID: 30858160 [TBL] [Abstract][Full Text] [Related]
7. Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data. Stavelin A; Flesche K; Tollaanes M; Christensen NG; Sandberg S Clin Chem Lab Med; 2020 Mar; 58(4):588-596. PubMed ID: 31821164 [TBL] [Abstract][Full Text] [Related]
8. Application of biological variation and sigma metrics to evaluate the performance of HbA Kang F; Li W; Lou Y; Shan Z Scand J Clin Lab Invest; 2022 Sep; 82(5):398-403. PubMed ID: 35872643 [TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of 55,769 HbA1c EQA results obtained from professional laboratories and medical offices participating in surveys organized by two European EQA centers over a nine-year period. Morandi PA; Deom A; Kesseler D; Cohen R J Clin Lab Anal; 2011; 25(5):337-43. PubMed ID: 21919068 [TBL] [Abstract][Full Text] [Related]
10. Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job? Delatour V; Clouet-Foraison N; Jaisson S; Kaiser P; Gillery P Clin Chem Lab Med; 2019 Sep; 57(10):1623-1631. PubMed ID: 31085744 [TBL] [Abstract][Full Text] [Related]
11. National continuous surveys on internal quality control for HbA1c in 306 clinical laboratories of China from 2012 to 2016: Continual improvement. Li T; Wang W; Zhao H; He F; Zhong K; Yuan S; Wang Z J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27868236 [TBL] [Abstract][Full Text] [Related]
12. Pharmacists' experience of a diabetes risk-assessment service and analytical quality control in community pharmacies - A focus-group study. Risøy AJ; Skeide Kjome RL; Svensberg K; Råheim M; Sølvik UØ Res Social Adm Pharm; 2021 Jul; 17(7):1259-1266. PubMed ID: 34155978 [TBL] [Abstract][Full Text] [Related]
13. HbA Kenealy T; Herd G; Musaad S; Wells S Prim Care Diabetes; 2019 Apr; 13(2):170-175. PubMed ID: 30545795 [TBL] [Abstract][Full Text] [Related]
14. Results from 15years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes. Shephard M; Shephard A; McAteer B; Regnier T; Barancek K Clin Biochem; 2017 Dec; 50(18):1159-1163. PubMed ID: 28734906 [TBL] [Abstract][Full Text] [Related]
15. Bridging the gap between point-of-care testing and laboratory testing in hemostasis. Kitchen DP; Jennings I; Kitchen S; Woods TA; Walker ID Semin Thromb Hemost; 2015 Apr; 41(3):272-8. PubMed ID: 25775047 [TBL] [Abstract][Full Text] [Related]
16. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program. Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194 [TBL] [Abstract][Full Text] [Related]
17. HbA1c: EQA in Germany, Belgium and the Netherlands using fresh whole blood samples with target values assigned with the IFCC reference system. Kaiser P; Spannagl M; van Campenhout C; Lenga Y; Siebelder C; Weykamp C Clin Chem Lab Med; 2016 Nov; 54(11):1769-1775. PubMed ID: 27171390 [TBL] [Abstract][Full Text] [Related]
18. Hemoglobin A1c point-of-care assays; a new world with a lot of consequences! Lenters-Westra E; Slingerland RJ J Diabetes Sci Technol; 2009 May; 3(3):418-23. PubMed ID: 20144277 [TBL] [Abstract][Full Text] [Related]
19. External quality assessment/proficiency testing and internal quality control for the PFA-100 and PFA-200: an update. Favaloro EJ; Bonar R Semin Thromb Hemost; 2014 Mar; 40(2):239-53. PubMed ID: 24497116 [TBL] [Abstract][Full Text] [Related]
20. Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Sølvik UØ; Bjelkarøy WI; Berg KVD; Saga AL; Hager HB; Sandberg S Clin Chem Lab Med; 2017 Oct; 55(12):1857-1864. PubMed ID: 28593925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]